evidence: Aluminum in vaccines: Does it create a safety problem? [...] Analysis of the literature showed that no apparent reason exists to support the elimination of Al from vaccines for fear of neurotoxicity. The only problem that deserves attention is the suggested relationship between Al oxyhydroxide-containing vaccines and macrophagic myofaciitis or myalgic encephalomyelitis/chronic fatigue syndrome. Currently, definitive conclusions cannot be drawn on these risks and further studies must be conducted. Until then, Al remains the best solution to improve vaccine efficacy. [...] - [Aluminium adjuvant exposure through vaccines in France in 2018].Ann Pharm Fr. 2020 Mar;78(2):111-128. doi: 10.1016/j.pharma.2020.01.002. Epub 2020 Jan 17. Ann Pharm Fr. 2020. PMID: 32081303 Review. French.